189 related articles for article (PubMed ID: 25336937)
1. Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors.
Izquierdo JL; Resano P; El Hachem A; Graziani D; Almonacid C; Sánchez IM
Int J Chron Obstruct Pulmon Dis; 2014; 9():1053-8. PubMed ID: 25336937
[TBL] [Abstract][Full Text] [Related]
2. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
[TBL] [Abstract][Full Text] [Related]
3. Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD.
Dong W; Du Y; Ma S
Int J Chron Obstruct Pulmon Dis; 2018; 13():3805-3812. PubMed ID: 30538442
[TBL] [Abstract][Full Text] [Related]
4. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection.
Sekine Y; Suzuki H; Yamada Y; Koh E; Yoshino I
Thorac Cardiovasc Surg; 2013 Mar; 61(2):124-30. PubMed ID: 22535670
[TBL] [Abstract][Full Text] [Related]
5. Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.
Dong W; Zhu Y; Du Y; Wang L; Feng X; Ma S
Clin Respir J; 2020 Apr; 14(4):345-352. PubMed ID: 31876095
[TBL] [Abstract][Full Text] [Related]
6. Role of emphysema and airway obstruction in prognosis of lung cancer.
Gullón JA; Suárez I; Medina A; Rubinos G; Fernández R; González I
Lung Cancer; 2011 Feb; 71(2):182-5. PubMed ID: 20554345
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
8. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection.
Sekine Y; Yamada Y; Chiyo M; Iwata T; Nakajima T; Yasufuku K; Suzuki M; Fujisawa T
Ann Thorac Surg; 2007 Sep; 84(3):946-50. PubMed ID: 17720404
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
Ciuleanu T; Stelmakh L; Cicenas S; Miliauskas S; Grigorescu AC; Hillenbach C; Johannsdottir HK; Klughammer B; Gonzalez EE
Lancet Oncol; 2012 Mar; 13(3):300-8. PubMed ID: 22277837
[TBL] [Abstract][Full Text] [Related]
10. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors.
de Torres JP; Marín JM; Casanova C; Cote C; Carrizo S; Cordoba-Lanus E; Baz-Dávila R; Zulueta JJ; Aguirre-Jaime A; Saetta M; Cosio MG; Celli BR
Am J Respir Crit Care Med; 2011 Oct; 184(8):913-9. PubMed ID: 21799072
[TBL] [Abstract][Full Text] [Related]
12. The impact of combined pulmonary fibrosis and chronic obstructive pulmonary disease on long-term survival after lung cancer surgery.
Sekine Y; Sakairi Y; Yoshino M; Koh E; Hata A; Suzuki H; Yoshino I
Thorac Cardiovasc Surg; 2014 Jun; 62(4):332-7. PubMed ID: 24879070
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of chronic obstructive pulmonary disease in ST-elevation myocardial infarction after primary angioplasty.
Lazzeri C; Valente S; Attanà P; Chiostri M; Picariello C; Gensini GF
Eur J Prev Cardiol; 2013 Jun; 20(3):392-8. PubMed ID: 22023803
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
[TBL] [Abstract][Full Text] [Related]
15. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
[TBL] [Abstract][Full Text] [Related]
16. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
[TBL] [Abstract][Full Text] [Related]
17. Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel.
Di Maio M; Krzakowski M; Fougeray R; Kowalski DM; Gridelli C
Lung Cancer; 2012 Jul; 77(1):116-20. PubMed ID: 22361218
[TBL] [Abstract][Full Text] [Related]
18. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
[TBL] [Abstract][Full Text] [Related]
19. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
20. Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapy.
Masago K; Togashi Y; Fujita S; Nagai H; Sakamori Y; Okuda C; Kim YH; Mishima M
Oncology; 2013; 84(4):214-8. PubMed ID: 23364242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
